Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Saved in:
| Title: | Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display. |
|---|---|
| Authors: | Wickström SL; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Lövgren T; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Volkmar M; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Reinhold B; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States., Duke-Cohan JS; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States., Hartmann L; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Rebmann J; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mueller A; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany., Melief J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Maas R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Ligtenberg M; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Hansson J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Offringa R; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany., Poschke I; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKTK Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Reinherz EL; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States., Kiessling R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. |
| Source: | Frontiers in immunology [Front Immunol] 2019 Dec 11; Vol. 10, pp. 2766. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2019.02766 |
